ZA786184B - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
ZA786184B
ZA786184B ZA00786184A ZA786184A ZA786184B ZA 786184 B ZA786184 B ZA 786184B ZA 00786184 A ZA00786184 A ZA 00786184A ZA 786184 A ZA786184 A ZA 786184A ZA 786184 B ZA786184 B ZA 786184B
Authority
ZA
South Africa
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Application number
ZA00786184A
Other languages
English (en)
Inventor
S Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA786184B publication Critical patent/ZA786184B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA00786184A 1977-11-05 1978-11-02 Therapeutic agents ZA786184B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4612877 1977-11-05

Publications (1)

Publication Number Publication Date
ZA786184B true ZA786184B (en) 1979-10-31

Family

ID=10439957

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00786184A ZA786184B (en) 1977-11-05 1978-11-02 Therapeutic agents

Country Status (36)

Country Link
JP (1) JPS5498792A (xx)
AR (2) AR219562A1 (xx)
AT (1) AT365186B (xx)
AU (1) AU509329B2 (xx)
BE (1) BE871771A (xx)
CA (1) CA1088059A (xx)
CH (1) CH643255A5 (xx)
CS (2) CS207671B2 (xx)
DD (1) DD139850A5 (xx)
DE (1) DE2847623C2 (xx)
DK (1) DK154082C (xx)
EG (1) EG13594A (xx)
ES (2) ES474805A1 (xx)
FI (1) FI64366C (xx)
FR (1) FR2407929A1 (xx)
GR (1) GR81514B (xx)
HK (1) HK94284A (xx)
HU (1) HU176306B (xx)
IE (1) IE47888B1 (xx)
IL (1) IL55857A (xx)
IN (1) IN148828B (xx)
IT (1) IT1100919B (xx)
KE (1) KE3350A (xx)
LU (2) LU80470A1 (xx)
MY (1) MY8500286A (xx)
NL (2) NL174549C (xx)
NO (1) NO150158C (xx)
NZ (1) NZ188813A (xx)
PH (1) PH13966A (xx)
PL (2) PL119586B1 (xx)
PT (1) PT68735A (xx)
SE (1) SE437518B (xx)
SU (1) SU816403A3 (xx)
UA (1) UA8324A1 (xx)
YU (2) YU40204B (xx)
ZA (1) ZA786184B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002617A1 (en) * 1983-12-14 1985-06-20 Takeda Chemical Industries. Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
WO1985004658A1 (en) * 1984-04-04 1985-10-24 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepine derivatives and their preparation
WO1986002644A1 (en) * 1984-11-01 1986-05-09 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
DE59611417D1 (de) * 1996-12-20 2007-03-29 Heumann Pharma Gmbh & Co Neue polymorphe Form von Doxazosinmesylat (Form III)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
TW448155B (en) * 1999-03-29 2001-08-01 Dev Center Biotechnology Method for producing amide compounds and quinazolin derivatives
EP1403263B1 (en) * 2002-09-27 2005-06-22 Council of Scientific and Industrial Research Process for the preparation of N-(2,3-dihydrobenzo 1,4 dioxin-2-carbonyl) piperazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines

Also Published As

Publication number Publication date
ES480121A0 (es) 1980-07-16
NL174549B (nl) 1984-02-01
YU40419B (en) 1985-12-31
YU255378A (en) 1983-06-30
NO783705L (no) 1979-05-08
DK154082B (da) 1988-10-10
DE2847623A1 (de) 1979-05-23
BE871771A (fr) 1979-05-03
JPS5498792A (en) 1979-08-03
AR223015A1 (es) 1981-07-15
NL930062I2 (nl) 1993-11-16
CH643255A5 (en) 1984-05-30
NL7810909A (nl) 1979-05-08
AR219562A1 (es) 1980-08-29
NL930062I1 (nl) 1993-09-01
IN148828B (xx) 1981-06-27
DK428678A (da) 1979-05-06
NZ188813A (en) 1980-10-08
DE2847623C2 (de) 1983-06-01
DK154082C (da) 1989-02-27
GR81514B (xx) 1984-12-11
IT1100919B (it) 1985-09-28
NL174549C (nl) 1984-07-02
ATA784378A (de) 1981-05-15
IE47888B1 (en) 1984-07-11
AU509329B2 (en) 1980-05-08
AU4132278A (en) 1979-05-17
IL55857A (en) 1982-07-30
FI64366B (fi) 1983-07-29
PL119419B1 (en) 1981-12-31
FR2407929B1 (xx) 1981-02-27
LU80470A1 (fr) 1980-06-05
CS354491A3 (en) 1992-06-17
HK94284A (en) 1984-12-07
MY8500286A (en) 1985-12-31
LU88331I2 (fr) 1994-05-04
ES474805A1 (es) 1980-01-16
CA1088059A (en) 1980-10-21
PL119586B1 (en) 1982-01-30
UA8324A1 (uk) 1996-03-29
IE782179L (en) 1979-05-05
AT365186B (de) 1981-12-28
SU816403A3 (ru) 1981-03-23
FI64366C (fi) 1983-11-10
JPS5625233B2 (xx) 1981-06-11
KE3350A (en) 1983-12-16
YU38683A (en) 1983-06-30
DD139850A5 (de) 1980-01-23
YU40204B (en) 1985-08-31
CS207671B2 (en) 1981-08-31
PH13966A (en) 1980-11-12
SE437518B (sv) 1985-03-04
IL55857A0 (en) 1979-01-31
HU176306B (en) 1981-01-28
FI783347A (fi) 1979-05-06
ES8308559A1 (es) 1980-07-16
SE7811382L (sv) 1979-05-06
IT7829434A0 (it) 1978-11-03
PT68735A (en) 1978-12-01
NO150158B (no) 1984-05-21
NO150158C (no) 1984-08-29
EG13594A (en) 1982-03-31
PL210681A1 (xx) 1979-11-05
FR2407929A1 (fr) 1979-06-01

Similar Documents

Publication Publication Date Title
GB2000136B (en) Therapeutic agents
GB2005248B (en) Therapeutic agents
ZA782816B (en) Therapeutic agents
GB2000138B (en) Therapeutic agents
ZA782919B (en) Hydantoin therapeutic agents
PH15198A (en) Therapeutic agents
GB2000131B (en) Therapeutic agents
ZA80298B (en) Therapeutic agents
AU507028B2 (en) Therapeutic agents
EG16606A (en) Therapeutic agents
ZA78413B (en) New therapeutic agents
GB2004876B (en) Therapeutic agents
GB2007656B (en) Therapeutic agents
ZA786184B (en) Therapeutic agents
PH14956A (en) Trans-broparestrol based therapeutic
ZA77776B (en) Therapeutic agents
ZA786259B (en) Therapeutic composition
ZA78554B (en) Novel therapeutic agents
GB2000510B (en) Therapeutic agents
GB2010824B (en) Therapeutic agents
GB2047691B (en) Therapeutic agents
GB2053910B (en) Pyridylaminotriazole therapeutic agents
JPS53117285A (en) Massager
GB2008104B (en) Therapeutic agents
GB2007654B (en) Therapeutic agents